Literature DB >> 9359707

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

V Iotsova1, J Caamaño, J Loy, Y Yang, A Lewin, R Bravo.   

Abstract

The nfkb1 and nfkb2 genes encode closely related products regulating immune and inflammatory responses. Their role during development and differentiation remains unclear. The generation of nfkb1 null mice (p50-/-) resulted in altered immune responses, but had no effect on development. Similarly, nfkb2 knockout mice (p52-/-) did not show developmental defects (J.C. et al., manuscript submitted). We have investigated the potential for in vivo compensatory functions of these genes by generating double-knockout mice. The surprising result was that the animals developed osteopetrosis because of a defect in osteoclast differentiation, suggesting redundant functions of NF-kappaB1 and NF-kappaB2 proteins in the development of this cell lineage. The osteopetrotic phenotype was rescued by bone marrow transplantation, indicating that the hematopoietic component was impaired. These results define a new mouse osteopetrotic mutant and implicate NF-kappaB proteins in bone development, raising new directions in the treatment of bone disorders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9359707     DOI: 10.1038/nm1197-1285

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  267 in total

Review 1.  Series introduction: the transcription factor NF-kappaB and human disease.

Authors:  A S Baldwin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

Authors:  D C Guttridge; C Albanese; J Y Reuther; R G Pestell; A S Baldwin
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

3.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

4.  IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.

Authors:  Y Abu-Amer
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 5.  New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.

Authors:  J C Crockett; D J Mellis; D I Scott; M H Helfrich
Journal:  Osteoporos Int       Date:  2010-05-11       Impact factor: 4.507

6.  Tyrosine phosphorylation is required for IkappaB kinase-beta (IKKbeta) activation and function in osteoclastogenesis.

Authors:  Isra Darwech; Jesse E Otero; Muhammad A Alhawagri; Yousef Abu-Amer
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 7.  NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions.

Authors:  Jorge Caamaño; Christopher A Hunter
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 8.  MicroRNAs and their roles in osteoclast differentiation.

Authors:  Zhuying Xia; Chao Chen; Peng Chen; Hui Xie; Xianghang Luo
Journal:  Front Med       Date:  2011-12-27       Impact factor: 4.592

9.  TRAF family member-associated NF-κB activator (TANK) is a negative regulator of osteoclastogenesis and bone formation.

Authors:  Kenta Maruyama; Tatsukata Kawagoe; Takeshi Kondo; Shizuo Akira; Osamu Takeuchi
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

10.  Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.

Authors:  W F Rodrigues; M F M Madeira; T A da Silva; J T Clemente-Napimoga; C B Miguel; V J Dias-da-Silva; O Barbosa-Neto; A H Lopes; M H Napimoga
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.